Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nabi Biopharmaceuticals (PentaStaph vaccine program)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A license for developing vaccine in Rockville, Maryland. The licence features development rights of a vaccine namely, PentaStaph, to be used against staphylococcal infections.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Acquirer
Primary Office
  • 12270 Wilkins Avenue
  • Rockville, MD 20852
  • United States

Nabi Biopharmaceuticals (PentaStaph vaccine program) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Nabi Biopharmaceuticals (PentaStaph vaccine program)‘s full profile, request access.

Request full access to PitchBook

Nabi Biopharmaceuticals (PentaStaph vaccine program) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Nabi Biopharmaceuticals (PentaStaph vaccine program)‘s full profile, request access.

Request full access to PitchBook